期刊文献+

肝硬化大鼠内脏血管组织内皮素及其基因表达的研究 被引量:1

Study on endothlin and its gene expression in Splanchnic vessels in cirrhotic rats
原文传递
导出
摘要 目的探讨肝硬化大鼠内脏血管组织中,内皮素(ET)及其基因表达量的变化在门静脉高压形成机制中的意义。方法用放射免疫法分别测定大鼠血浆以及门静脉(PV)和肠系膜上动脉(SMA)组织中ET含量,采用RT-PCR技术分析PV和SMA组织中ETmRNA表达量的变化。结果PV和SMA组织中ET及其mRNA表达量,肝硬化组均显著高于正常对照组(均为P<0.001);而肝硬化大鼠血管组织ET含量及ETmRNA表达量,则为PV明显高于SMA(<0.05),但正常对照组动静脉之间差异无显著性(P>005)。另外,内脏动静脉血管ET含量之差与门静脉压力呈显著的正相关。结论ET可能通过更多的收缩内脏静脉特别是门静脉,增加门静脉血流阻力而参与门静脉高压的形成。 Objective To investigate the role of endothlin(ET) in the pathogenesis of portalhnyftension, ET-l level and its gene expression in splanchnic vessels from cirrhotic rats were oberved.Methods ET levels of both plasma and vascular tissues were determined by radioimmunoassay. ET mRNAin vascular tissues was plotal with RT-PCR technique expressed as optical density(OD) value from imageanalysis. Results ET peptide and mRNA in PV and SMA vessels were all significantly higher in cirrhoticrats than those in normal rats, while in cirrhotic rats, ET and its gene expression of PV was dramaticallyhigher than that of SMA(P<0.05). In addition, the positive correlation was oborved in difference betweenPV and SMA in ET concentration with portal pressure(r=0.737, p<0.0l). Conclusion ET may be involved in the machanisms of the formation of PObal hrmrt6nsion mainly due to constructing portal vein,increassing portal flow resistance.
出处 《中华肝脏病杂志》 CAS CSCD 1999年第4期233-235,共3页 Chinese Journal of Hepatology
关键词 内皮素 基因表达 门静脉高压 肝硬化 Endothiln Gene expression Portal hypertension
  • 相关文献

参考文献2

  • 1Baner M,Am J Physiol G,1994年,267卷,143页
  • 2Luncher T F,Circulation Research,1990年,66卷,1088页

同被引文献16

  • 1杨晋辉,余曙光,尤丽英,常江,李俊,徐嫦玉.自体腹水浓缩后腹腔回输治疗顽固性腹水[J].中华内科杂志,1996,35(7):476-477. 被引量:57
  • 21,Francis JD.Puthophysiolocy of ascites formation.Gastroenterol Clin North Am, 1992,21(1):215~235
  • 32,Fernandez-Seare J,Prieto J,Quiroga J, et al.Systemic and regional hemodyn amics in patients with liver cirrhosis and ascites with and without functional r enal.Gastroenterology,1989,97(5):1304~1312
  • 43,Macgilchrist AJ.Sumner D,Reid JL.Impaired pressor reactivity in cir rh osis:evidence for a peripheral vasculat defeet.Hepatology,1990,11(5):869~876
  • 55,Kaneda K,Ekataksin W,Sogawa M,et al.Endothlin-1-induced vasocostr ic ton causes a significant increase in portal pressure of rat liver:localized cons trictive effect on the distal segment of preterminal portal venules as revealed by light and electron microscopy and serial reconstruction.Hepatology,1998,27:73 5~747
  • 68,Moorek.In:Progress in hepatology.Athens,1994,80:425
  • 710,Moller S,Bendtsen F,Schifter S,et al.Relation of calcitonin genere lated peptide to systemic vasodilatation and central hypovolemia in cirrhosis.Sc and J gastroenterol,1996,31:928~933
  • 812,Arroyo V,Ginés P,Planas R.Treatment of ascites in cirrhosis.Gastr oenterol Clin North Am,1992,21(1):237~256
  • 913,Angeli P,Dalla-Pria M,De-Bei E, et al.Randomized clinical study of the efficacy of amiloride and potassium canrenoate in nonazotemic cirrhotic patients with ascit es.Hepatology,1994,19(5):1095~1099
  • 1014,Garcia-Pagán JC,Feu, FGastells A, et al.Effects of low-sodium d iet and spiro nolactone on portal pressure in patients with compensated cirrhosis.Hepatology,1 994,19(5):1095~1099

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部